Celldex Therapeutics
CLDX
CLDX
95 hedge funds and large institutions have $23.2M invested in Celldex Therapeutics in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
15% less capital invested
Capital invested by funds: $27.4M → $23.2M (-$4.23M)
32% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 31
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Holders
95
Holding in Top 10
2
Calls
$11K
Puts
$13K
Top Buyers
| 1 | +$506K | |
| 2 | +$284K | |
| 3 | +$190K | |
| 4 |
Two Sigma Investments
New York
|
+$164K |
| 5 |
Two Sigma Advisers
New York
|
+$153K |
Top Sellers
| 1 | -$669K | |
| 2 | -$666K | |
| 3 | -$405K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$323K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$289K |